{"transactions":[{"id":1472172,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T16:07:22.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 20, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":32500,"derivative":{"exercise_price":4.05,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001662579-24-000056","document":"wk-form4_1719000433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000166257924000056/wk-form4_1719000433.xml","form_type":"4"}},{"id":1852548,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:22:12.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":26000,"derivative":{"exercise_price":3.61,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001662579-23-000055","document":"wk-form4_1686946925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000166257923000055/wk-form4_1686946925.xml","form_type":"4"}},{"id":2223140,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T16:15:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":6.06,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-22-038862","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919122038862/doc4.xml","form_type":"4"}},{"id":2433910,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T16:30:40.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":428,"price":31.58,"value":13516.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022."}],"balance_after":11380,"source":{"system":"sec-edgar","filing":"0001209191-22-003504","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919122003504/doc4.xml","form_type":"4"}},{"id":2466529,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-17T16:28:45.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":755,"price":30.25,"value":22838.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021."}],"balance_after":10952,"source":{"system":"sec-edgar","filing":"0001209191-21-070273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121070273/doc4.xml","form_type":"4"}},{"id":2503197,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T16:30:28.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":755,"price":40.11,"value":30283.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021."}],"balance_after":11707,"source":{"system":"sec-edgar","filing":"0001209191-21-065820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121065820/doc4.xml","form_type":"4"}},{"id":2541764,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-15T16:36:20.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":755,"price":44.94,"value":33929.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021."}],"balance_after":12462,"source":{"system":"sec-edgar","filing":"0001209191-21-060568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121060568/doc4.xml","form_type":"4"}},{"id":2549367,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T16:56:45.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":300,"price":44.99,"value":13497.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021."}],"balance_after":13217,"source":{"system":"sec-edgar","filing":"0001209191-21-059530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121059530/doc4.xml","form_type":"4"}},{"id":2563177,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-21T19:25:33.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":755,"price":49.89,"value":37666.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021."}],"balance_after":12917,"source":{"system":"sec-edgar","filing":"0001209191-21-057117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121057117/doc4.xml","form_type":"4"}},{"id":2592492,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-24T17:01:12.000Z","date":"2021-08-20","kind":"sale","acquired":false,"shares":755,"price":40.73,"value":30751.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021."}],"balance_after":13672,"source":{"system":"sec-edgar","filing":"0001209191-21-053162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121053162/doc4.xml","form_type":"4"}},{"id":2630742,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-19T16:30:13.000Z","date":"2021-07-16","kind":"sale","acquired":false,"shares":755,"price":37.37,"value":28214.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021."}],"balance_after":14427,"source":{"system":"sec-edgar","filing":"0001209191-21-047169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121047169/doc4.xml","form_type":"4"}},{"id":2639652,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T16:30:19.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":339,"price":39.72,"value":13465.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021."}],"balance_after":15182,"source":{"system":"sec-edgar","filing":"0001209191-21-045808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121045808/doc4.xml","form_type":"4"}},{"id":2661489,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:23:07.000Z","date":"2021-06-18","kind":"sale","acquired":false,"shares":755,"price":37.19,"value":28078.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021."}],"balance_after":14843,"source":{"system":"sec-edgar","filing":"0001209191-21-042300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121042300/doc4.xml","form_type":"4"}},{"id":2664124,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T16:15:51.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":37.66,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-21-041425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121041425/doc4.xml","form_type":"4"}},{"id":2699218,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T18:42:21.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":755,"price":37.12,"value":28025.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021."}],"balance_after":15598,"source":{"system":"sec-edgar","filing":"0001209191-21-035501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121035501/doc4.xml","form_type":"4"}},{"id":2755925,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-06T16:30:49.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":359,"price":37.51,"value":13466.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021."}],"balance_after":16353,"source":{"system":"sec-edgar","filing":"0001209191-21-025663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000120919121025663/doc4.xml","form_type":"4"}},{"id":3011819,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-10-06T21:26:01.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":23809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2823},"source":{"system":"sec-edgar","filing":"0000899243-20-027692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000089924320027692/doc4.xml","form_type":"4"}},{"id":3011818,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-06T21:26:01.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11856},"source":{"system":"sec-edgar","filing":"0000899243-20-027692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000089924320027692/doc4.xml","form_type":"4"}},{"id":3011817,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:26:01.000Z","date":"2020-10-06","kind":"purchase","acquired":true,"shares":1315,"price":19,"value":24985.0,"ownership":{"direct":true},"balance_after":15994,"source":{"system":"sec-edgar","filing":"0000899243-20-027692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000089924320027692/doc4.xml","form_type":"4"}},{"id":3011816,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:26:01.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":2823,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":14679,"source":{"system":"sec-edgar","filing":"0000899243-20-027692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000089924320027692/doc4.xml","form_type":"4"}},{"id":3011815,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:26:01.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":11856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":11856,"source":{"system":"sec-edgar","filing":"0000899243-20-027692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000089924320027692/doc4.xml","form_type":"4"}},{"id":3013651,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89659,"kind":"person","name":"Salter Malcolm","position":1,"cik":"0001825124","reported_name":"Salter Malcolm","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-05T21:00:26.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable upon the earlier to occur of (i) October 1, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":17786,"derivative":{"exercise_price":19,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0000899243-20-027449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825124/000089924320027449/doc4.xml","form_type":"4"}}]}